Insite Vision was an ophthalmic product development company focused on ophthalmic pharmaceutical products based on its proprietary DuraSite® drug delivery technology. Beginning in 2007, it has expanded beyond ophthalmic products to other topical anti-infectives, including the treatment of ear infections. The company' s intent is to continue to solidify its franchise in ocular anti-infective topical therapies as well as extend its anti-infective platform to non-ocular topical products. DuraSite® sustained delivery technology is a proven, patented synthetic polymer-based formulation designed to extend the residence time of a drug relative to conventional topical therapies.